Feasibility of a pharmacist-led physical health monitoring for patients on antipsychotic medications: protocol for a longitudinal study
Introduction Physical health conditions are the leading causes of death in people living with severe mental illness. In particular, the risk of metabolic syndrome; the constellation of abnormalities in weight, blood pressure, blood glucose and lipid levels, is high in this cohort. It has been recogn...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/6/e059573.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832590059479498752 |
|---|---|
| author | Fiona Kelly Tien Ngoc Thi Bui Elizabeth Hotham Vijayaprakash Suppiah |
| author_facet | Fiona Kelly Tien Ngoc Thi Bui Elizabeth Hotham Vijayaprakash Suppiah |
| author_sort | Fiona Kelly |
| collection | DOAJ |
| description | Introduction Physical health conditions are the leading causes of death in people living with severe mental illness. In particular, the risk of metabolic syndrome; the constellation of abnormalities in weight, blood pressure, blood glucose and lipid levels, is high in this cohort. It has been recognised that commonly prescribed pharmacological agents for mental illness can further amplify the risk of developing metabolic syndrome; therefore, monitoring guidelines are in place for consumers prescribed antipsychotics. However, there is a disconnect between recommended guidelines and current practice. Our study aims to investigate: (1) the feasibility of a community pharmacist-led physical health monitoring for metabolic parameters in consumers with mental illness currently taking second generation antipsychotics and (2) the potential outcomes of the intervention (eg, rates and outcome of referrals to general practitioners, relationship between the pharmacist’s lifestyle counselling advice and change in metabolic parameters).Methods and analysis We propose a longitudinal metabolic monitoring study led by community pharmacists with one-to-one consultations between trained pharmacists and participants at set intervals over a 12-month period. Our primary outcome is to determine the feasibility of the pharmacist-led intervention. The secondary outcome is to explore the overall health outcomes of consumers enrolled in the intervention. This is a mixed-methods study including both quantitative and qualitative outcomes. Qualitative data will be analysed via the process of data immersion, coding and identification of themes. Quantitative outcomes will be analysed using IBM Statistics SPSS software. Univariate descriptive, regression analysis and dependent t-tests will be performed. Statistical significance will be at α 0.05.Ethics and dissemination Our study has been approved by the institutional Human Research Ethics Committee (Protocol no: 203433). Findings will be made publicly available in peer-reviewed articles, conference presentations to health professionals, as well as other stakeholders. Protocol V.2.1, August 2021.Trial registration number ACTRN12621001435875. |
| format | Article |
| id | doaj-art-7e3689173515426c80ff6c66578bce07 |
| institution | Kabale University |
| issn | 2044-6055 |
| language | English |
| publishDate | 2022-06-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-7e3689173515426c80ff6c66578bce072025-01-24T02:40:09ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2021-059573Feasibility of a pharmacist-led physical health monitoring for patients on antipsychotic medications: protocol for a longitudinal studyFiona Kelly0Tien Ngoc Thi Bui1Elizabeth Hotham2Vijayaprakash Suppiah3Quality Use of Medicines Network, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, AustraliaClinical and Health Sciences, University of South Australia, Adelaide, South Australia, AustraliaClinical and Health Sciences, University of South Australia, Adelaide, South Australia, AustraliaClinical and Health Sciences, University of South Australia, Adelaide, South Australia, AustraliaIntroduction Physical health conditions are the leading causes of death in people living with severe mental illness. In particular, the risk of metabolic syndrome; the constellation of abnormalities in weight, blood pressure, blood glucose and lipid levels, is high in this cohort. It has been recognised that commonly prescribed pharmacological agents for mental illness can further amplify the risk of developing metabolic syndrome; therefore, monitoring guidelines are in place for consumers prescribed antipsychotics. However, there is a disconnect between recommended guidelines and current practice. Our study aims to investigate: (1) the feasibility of a community pharmacist-led physical health monitoring for metabolic parameters in consumers with mental illness currently taking second generation antipsychotics and (2) the potential outcomes of the intervention (eg, rates and outcome of referrals to general practitioners, relationship between the pharmacist’s lifestyle counselling advice and change in metabolic parameters).Methods and analysis We propose a longitudinal metabolic monitoring study led by community pharmacists with one-to-one consultations between trained pharmacists and participants at set intervals over a 12-month period. Our primary outcome is to determine the feasibility of the pharmacist-led intervention. The secondary outcome is to explore the overall health outcomes of consumers enrolled in the intervention. This is a mixed-methods study including both quantitative and qualitative outcomes. Qualitative data will be analysed via the process of data immersion, coding and identification of themes. Quantitative outcomes will be analysed using IBM Statistics SPSS software. Univariate descriptive, regression analysis and dependent t-tests will be performed. Statistical significance will be at α 0.05.Ethics and dissemination Our study has been approved by the institutional Human Research Ethics Committee (Protocol no: 203433). Findings will be made publicly available in peer-reviewed articles, conference presentations to health professionals, as well as other stakeholders. Protocol V.2.1, August 2021.Trial registration number ACTRN12621001435875.https://bmjopen.bmj.com/content/12/6/e059573.full |
| spellingShingle | Fiona Kelly Tien Ngoc Thi Bui Elizabeth Hotham Vijayaprakash Suppiah Feasibility of a pharmacist-led physical health monitoring for patients on antipsychotic medications: protocol for a longitudinal study BMJ Open |
| title | Feasibility of a pharmacist-led physical health monitoring for patients on antipsychotic medications: protocol for a longitudinal study |
| title_full | Feasibility of a pharmacist-led physical health monitoring for patients on antipsychotic medications: protocol for a longitudinal study |
| title_fullStr | Feasibility of a pharmacist-led physical health monitoring for patients on antipsychotic medications: protocol for a longitudinal study |
| title_full_unstemmed | Feasibility of a pharmacist-led physical health monitoring for patients on antipsychotic medications: protocol for a longitudinal study |
| title_short | Feasibility of a pharmacist-led physical health monitoring for patients on antipsychotic medications: protocol for a longitudinal study |
| title_sort | feasibility of a pharmacist led physical health monitoring for patients on antipsychotic medications protocol for a longitudinal study |
| url | https://bmjopen.bmj.com/content/12/6/e059573.full |
| work_keys_str_mv | AT fionakelly feasibilityofapharmacistledphysicalhealthmonitoringforpatientsonantipsychoticmedicationsprotocolforalongitudinalstudy AT tienngocthibui feasibilityofapharmacistledphysicalhealthmonitoringforpatientsonantipsychoticmedicationsprotocolforalongitudinalstudy AT elizabethhotham feasibilityofapharmacistledphysicalhealthmonitoringforpatientsonantipsychoticmedicationsprotocolforalongitudinalstudy AT vijayaprakashsuppiah feasibilityofapharmacistledphysicalhealthmonitoringforpatientsonantipsychoticmedicationsprotocolforalongitudinalstudy |